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Abstract
Introduction
It is estimated that up to 75% of premenopausal women experience at least one premen-
strual symptom and 8–20% meet clinical criteria for premenstrual syndrome. Premenstrual
syndrome substantially reduces quality of life for many women of reproductive age, with
pharmaceutical treatments having limited efficacy and substantial side effects. Physical
activity has been recommended as a method of reducing menstrual symptom severity. How-
ever, this recommendation is based on relatively little evidence, and the relationship
between physical activity, premenstrual symptoms, and premenstrual syndrome remains
unclear.
Methods
We evaluated the relationship between physical activity and premenstrual syndrome and
premenstrual symptoms among 414 women aged 18–31. Usual premenstrual symptom
experience was assessed with a modified version of the Calendar of Premenstrual Experi-
ences. Total, physical, and affective premenstrual symptom scores were calculated for all
participants. Eighty women met criteria for moderate-to-severe premenstrual syndrome,
while 89 met control criteria. Physical activity, along with dietary and lifestyle factors, was
assessed by self-report.
Results
Physical activity was not significantly associated with total, affective, or physical premen-
strual symptom score. Compared to the women with the lowest activity, women in tertiles 2
and 3 of activity, classified as metabolic equivalent task hours, had prevalence odds ratios
for premenstrual syndrome of 1.5 (95% CI: 0.6–3.7) and 0.9 (95% CI: 0.4–2.4), respectively
(p-value for trend = 0.85).
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Conclusions
We found no association between physical activity and either premenstrual symptom scores
or the prevalence of premenstrual syndrome.
Introduction
It is estimated that up to 75% of premenopausal women experience at least physical or emo-
tional symptom in the two weeks before menses begins [1,2]. Common premenstrual symp-
toms range from emotional and behavioral symptoms such as depression, angry outbursts,
irritability, crying spells, anxiety, confusion, social withdrawal, poor concentration, sleep dis-
turbance, and thirst and appetite changes, to physical symptoms including breast tenderness,
bloating and weight gain, headache, swelling of the hands or feet, and aches or pains [1].
While premenstrual symptoms are common, a smaller proportion of women meet clinical
criteria for premenstrual syndrome (PMS). Occurring in 8–20% of premenopausal women,
PMS is associated with substantial reduction in quality of life [3,4]. The causes of PMS are
unclear, though an underlying neurobiological vulnerability to normal fluctuations in the cir-
culating sex hormones levels during the menstrual cycle [5,6] is thought to contribute. Hor-
monal fluctuations may also alter brain neurotransmitter or neuropeptide function [5,6],
contributing to both emotional and physical symptoms. In particular, some studies have
observed luteal phase abnormalities in serotonin function in women with PMS compared to
symptom free controls [5]. Despite the high prevalence of PMS, there are relatively few treat-
ment options available. Recreational physical activity has been recommended as a method of
reducing PMS occurrence and severity and as an alternative to pharmaceutical treatments in
easing symptoms [7]. Aerobic physical activity may increase endorphin levels [5,8], decrease
levels of estradiol and other steroid hormones, [9,10] improve transport of oxygen in muscles
[9], reduce cortisol levels [9], and improve psychological well-being [8,11]. It is hypothesized
that frequent physical activity may, at least in part, reduce PMS and premenstrual symptoms
through these mechanisms.
Previous observational studies examining the relationship between physical activity and
PMS have demonstrated inconsistent findings. Several studies suggest a protective effect
[8,11–19], one showed no association [20], and two studies found higher levels of premen-
strual symptoms among women who exercised more compared to those exercising less or not
at all [21,22]. Multiple factors could contribute to the differences in findings between studies.
First, only one study [21] adjusted for body mass index (BMI), which has been positively asso-
ciated with premenstrual symptoms and PMS [23,24] and is correlated with physical activity
level. Failure to control for BMI may thus lead to confounding due to the underlying relation-
ship between physical activity and BMI. Secondly, results from observational studies assessing
premenstrual symptoms and physical activity may be affected by reverse causality, as women
may use exercise as a way to relieve symptoms.
To address the limitations of existing studies, we explicitly evaluated the prevalence of pre-
menstrual symptoms and PMS in 414 young adult women. As the etiology of PMS is still
unclear, identifying modifiable risk factors is important to improve the quality of life for
women of reproductive age [6]. Our objectives were to 1) examine the association between
physical activity and prevalent PMS and premenstrual symptom severity; 2) investigate the
impact of confounding by BMI; and 3) evaluate the potential for reverse causality through self-
reported use of exercise to treat premenstrual symptoms. We hypothesized that young women
who participated in recreational physical activity would be less likely to experience PMS and
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moderate-severe menstrual symptoms compared to women who participated in less physical
activity; results adjusted for BMI would be stronger than those unadjusted for BMI; and
including a self-reported “exercise to treat PMS” variable in our models would control for the
potential of reverse causality.
Methods
Study design and population
This study was approved by the Institutional Review Board at the University of Massachusetts
Amherst. All participants provided their written informed consent to participate. Study partic-
ipants were healthy women aged 18–31 recruited into the UMass Vitamin D Status Study
between 2006 and 2014. The study protocol has been described in detail previously [25,26].
In brief, women were ineligible to participate if they were pregnant or not currently men-
struating; were experiencing untreated depression; reported high blood pressure or elevated
cholesterol, kidney or liver disease, bone disease such as osteomalacia, digestive disorders,
rheumatologic disease, multiple sclerosis, thyroid disease, hyperparathyroidism, cancer, type 1
or type 2 diabetes, or polycystic ovaries; or were currently using corticosteroids. All study mea-
surements took place during the late luteal/high hormone phase of each participant’s men-
strual cycle (i.e., 5–7 days before the anticipated start of menses). Participants reported the
actual start date of next menses via email to confirm that measurements were conducted dur-
ing the luteal phase for each participant.
Assessment of physical activity
Participation in recreational physical activity was assessed by questionnaire, on which women
were asked to report the average time they spent each week over the past month engaging in
specific activities including walking, hiking, jogging, running, bicycling, aerobics or dancing,
tennis or other racket sports, swimming, yoga or pilates, and weight training. Response
options ranged from zero minutes to 11+ hours per week. Questionnaire responses were used
to calculate metabolic equivalent task (MET) hours per week, with one MET defined as the
energy expended while sitting quietly [27]. Our questionnaire was adapted from that used sim-
ilarly in the Nurses’ Health Study 2; the validity of these questions to assess physical activity
among young women has been demonstrated previously [28].
Assessment of premenstrual symptoms and PMS
Information on premenstrual symptoms was collected through self-reported questionnaire
using a modified version of the Calendar of Premenstrual Experiences (COPE) designed by
Mortola et al. [29] and similar to that used in the Nurses’ Health Study 2 Premenstrual Syn-
drome Sub-Study [30]. In a recent validation study, we found that the sensitivity of the modi-
fied COPE questionnaire versus prospective symptom diaries to identify PMS cases was 73%,
while positive predictive value was 80% and the specificity of our questionnaire versus daily
symptom diaries to identify controls was 73%, while the negative predictive value was 100%
[31].
Participants were asked if they experienced any of 26 different symptoms most months and
to indicate the usual severity of each symptom as none, mild, moderate, or severe. Responses
were individually scored from 1–4 (none = 1, mild = 2, moderate = 3, severe = 4) and summed
across symptoms to derive subscores for affective symptoms (n = 8 symptoms; range of possi-
ble scores = 8–32), physical or behavioral symptoms (n = 18 symptoms; range of possible
scores = 18–72), and a total premenstrual symptom score (range of possible scores = 26–104).
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Additionally, participants were asked to report whether they experienced relationship discord
with family or a partner; relationship discord with friends or coworkers; poor work perfor-
mance or attendance; or social isolation, and to indicate the severity of each as not a problem,
mild, moderate, or severe. Women were also asked to report whether they had ever used exer-
cise, dietary supplements or other factors to treat their symptoms.
A woman was considered a case if she reported moderate or severe symptoms starting at
the luteal phase and ending within a week of the start of menses, following methods used in
previous analyses in our study population [31,32]. Controls were women who reported no or
mild symptoms with little impact on life activities and relationships. Both cases and controls
had no evidence of a comorbid psychiatric disorder, including use of anti-depressant medica-
tions (see S1 Appendix for more detailed information on case/control identification).
Covariate assessment
Covariate information was collected through questionnaire measuring factors including age,
race, menstrual cycle information (including age at first menses, number of years after onset of
menstruation before cycle became regular, current usual length of menstrual cycle, number of
days of bleeding during period, and current usual pattern of menstrual cycles), current oral
contraceptive use, pregnancy status (ever vs. never) and ever smoker status (defined as>20
packs of cigarettes smoked in lifetime). Two modified versions of the Harvard Food Frequency
Questionnaire was used to estimate daily intake of vitamin D (IU), vitamin B6 (mg), and cal-
cium (mg) consumption intake from both dietary and supplemental sources, as well as daily
intake of alcohol (grams) and caffeine (mg) (Original version, 2006–08; Updated version,
2009–2014). Nutritional intake variables were adjusted for total energy using the residual
method [33]. Height and weight were measured directly and used to calculate BMI (weight
[kg]/height [m]2).
Statistical analysis
We started by examining bivariate relationships of characteristics of our study participants by
PMS case/control status. For continuous factors, Student’s t-test was used to examine mean
differences between PMS cases and controls. Bivariate associations for categorical variables
were examined using likelihood ratio chi-squared tests. To determine covariates in our multi-
variable models, we ran a forward selection logistic regression model (α = 0.10) predicting
case/control status from tertiles of physical activity (in METs). Age and BMI were included as
a priori covariates. Additional covariates in our multivariable models included calcium intake,
age at first menses (12 vs.>12), and ever smoker (yes vs. no). Finally, to address the possibil-
ity of reverse causality, we took into consideration whether women reported specifically using
exercise to treat premenstrual symptoms. We ran a complete case analysis in our multivariable
models and utilized the Hosmer-Lemeshow test to examine goodness-of-fit in our logistic
models.
To assess the association between physical activity and risk of PMS, we examined physical
activity by continuous METs per week and by tertiles of physical activity. To examine if physi-
cal activity was associated with the severity of premenstrual symptoms overall, we evaluated
how physical activity was associated with each of the three premenstrual symptom scores
(total, affective, and physical) using linear regression. We included all women in our sample in
this analysis to evaluate how physical activity correlates with symptoms across a wide range of
symptom experience and severity.
The relationship between physical activity and PMS status was modeled using multivariable
logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Two
Physical Activity and Premenstrual Syndrome
PLOS ONE | DOI:10.1371/journal.pone.0169728 January 12, 2017 4 / 13
analyses were conducted; the first examined physical activity categorized into tertiles of METs
per week and the second examined continuous physical activity in units of 10 METs per week.
We included only women who met PMS case or control criteria in these models; women meet-
ing neither criterion were excluded. This allowed us to compare women at extreme ends of the
menstrual symptom experience and is consistent with previous studies of behavioral risks for
PMS [25,30].
Data analyses were performed using SAS software, Version 9.4 for Windows (SAS Institute
Inc., Cary, NC, USA).
Results
A total of 414 women participated in our study. The average age of the participants was 21.0
years (+/- 2.6), mean BMI was 23.1 kg/m2 (+/- 3.4), and 45% of our sample currently used oral
contraceptives (Table 1). Of these women, 80 (19.3% of our sample) met criteria for PMS,
while 89 (21.5%) met control criteria. PMS cases were more likely to have experienced their
first menses at age 12 or younger (p<0.01) compared to controls. Controls had a higher intake
of calcium than cases (p<0.01). Other factors did not differ statistically between PMS cases
and controls.
PMS symptom severities are presented in Table 2. All 26 physical and affective symptoms
experienced for at least several days prior to the onset of menses were reported to be more
severe by cases compared to controls; cases reported an average total symptom severity score
23 points higher than controls (p< .01). The symptoms most frequently rated as “severe” by
all participants included the tendency to cry easily (25.2%), emotional hypersensitivity
(22.8%), irritability (22.1%), food cravings (20.5%), mood swings (17.3%), cramps (14.2%),
and appetite changes (13.4%) (data not shown).
We did not find physical activity to be associated with total premenstrual symptom score,
either with or without controlling for BMI (Table 3). Each 10 MET increase in activity was
associated with a 0.10 point increase in total symptom score in the model adjusted for age,
BMI, smoking status, age at first menses, and calcium intake (p = 0.40). Results were similar
for affective symptom and physical symptom scores.
In analyses comparing women meeting criteria for PMS vs. controls, we found that controls
exercised an average of 8.3 METs per week more than cases, although this difference was not
significant (54.8 vs. 46.6 METs/week; p = 0.21) (Table 4). After adjusting for BMI and other
factors, we did not find physical activity to be related to the prevalence of PMS. Compared to
women in the lowest tertile of physical activity, the prevalence odds ratio for women in tertiles
2 and 3 were 1.5 (95% CI: 0.6–3.7) and 0.9 (95% CI: 0.4–2.4), respectively (p-value for trend =
0.85). Similarly, there was no association between METs per week evaluated as a continuous
variable and prevalence of PMS (adjusted OR: 1.00; 95% CI: 0.99–1.01).
The null associations between PMS variables and physical activity persisted with further
adjustment for use of exercise to treat symptoms (Tables 3 and 4). However, total and physical
symptoms scores for PMS were significantly higher in those reporting exercise to treat symp-
toms (n = 107), with 3 points higher in total symptom score (p = 0.03) and a 2.5 point increase
in physical symptom score compared to women not reporting exercise to treat symptoms
(p<0.01), after adjusting for physical activity, age, BMI, ever smoker, age at first menses, and
calcium intake (Table 5).
Discussion
In this cross-sectional study, we found no evidence of an association between physical activity
and either prevalent PMS or premenstrual symptom severity. Results were similarly null when
Physical Activity and Premenstrual Syndrome
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Table 1. Characteristics of study participants (n = 414) and comparison between PMS cases (n = 80) and controls (n = 89)*.
Characteristics§ Total Sample PMS Case PMS Control p-value†
n = 414 n = 80 n = 89
Mean ± SD Mean ± SD Mean ± SD
Age (years) 21.0 ± 2.6 20.9 ± 2.5 20.9 ± 2.5 0.94
BMI (kg/m2) 23.1 ± 3.4 22.9 ± 3.3 22.7 ± 3.0 0.60
Vitamin D intake (IU/day) 132.1 ± 104.3 121.2 ± 96.8 151.2 ± 119.1 0.08
Calcium intake (mg/day)* 423.2 ± 164.7 385.6 ± 134.6 461.0 ± 185.4 <0.01
Vitamin B6 intake (mg/day)* 2.2 ± 3.6 2.2 ± 3.9 1.6 ± 1.3 0.25
Current alcohol intake (grams/day)* 2.7 ± 2.9 2.5 ± 2.0 2.7 ± 2.8 0.68
Daily caffeine consumption (mg/day)* 34.2 ± 35.4 37.5 ± 35.0 28.8 ± 36.5 0.16
n (%) n (%) n (%)
Race
• White 340 (82.1) 59 (73.8) 75 (84.3) 0.09
• Other 74 (17.9) 21 (26.3) 14 (15.6)
Age at first menses
•12 221 (53.4) 53 (66.3) 39 (43.8) <0.01
• >12 193 (46.6) 27 (33.8) 50 (56.2)
Number of years after onset of menses before cycle became regular
• <1 year 132 (32.0) 21 (26.3) 30 (33.7) 0.70
• 1–2 years 138 (33.4) 27 (33.8) 34.8)
• 3–4 years 85 (20.6) 21 (26.3) 20.2)
• >5 years 30 (7.3) 5 (6.3) (3.4)
• Never 28 (6.8) 6 (7.5) 7 (7.9)
Current usual length of menstrual cycle
• <21 days 5 (1.2) 1 (1.3) 1 (1.1) 0.61
• 21–25 days 94 (22.7) 17 (21.3) 24.7)
• 26–31 days 261 (63.0) 54 (67.5) 67.4)
• 32–39 days 31 (7.5) 4 (5.0) (3.4)
• >40 days 12 (2.9) 2 (2.5) (3.4)
• Too irregular to calculate 11 (2.7) 2 (2.5) 0 (0.0)
Days of bleeding during menses
•3 days 56 (13.6) 11 (13.8) 15 (16.9) 0.85
• 4–5 days 274 (66.3) 52 (65.0) 65.2)
• 6–7 days 80 (19.4) 15 (18.9) 16.9)
•8 days 3 (0.7) 2 (2.5) 1 (1.1)
Current usual pattern of menstrual cycles (days before or after expected menses)
• Extremely regular (within 1–2 days) 157 (37.9) 25 (31.3) 38 (42.7) 0.37
• Very regular (within 3–4 days) 116 (28.0) 29 (36.3) 28.1)
• Regular (within 5–7 days) 110 (26.6) 23 (28.8) 23.6)
• Usually/always irregular 31 (7.5) 3 (3.8) 5 (5.6)
Ever been pregnant
• Yes 11 (2.7) 4 (5.0) 3 (3.4) 0.60
• No 403 (97.3) 76 (95.0) 86 (96.6)
Current oral contraceptive use
• Yes 186 (44.9) 42 (52.5) 49 (55.1) 0.74
• No 228 (55.1) 38 (47.5) 40 (44.9)
Ever smoker
(Continued)
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we controlled for BMI and when we considered the use of exercise to treat premenstrual
symptoms.
We found that many of our participants experienced at least one premenstrual symptom
around the time of their expected menses. Identifying modifiable risk factors, such as physical
activity, is important to help improve premenstrual symptom severity in women who may not
need or want a pharmacological remedy. However, unlike some prior studies [8,11–15,17,18],
we did not find a lower prevalence of PMS or premenstrual symptoms in women who partici-
pated in high levels of physical activity compared to women who participated in lower levels or
no physical activity. We also did not find that a relationship between physical activity and PMS
was confounded by BMI. To our knowledge, only one other study of physical activity and PMS
adjusted for BMI [21]. This study found an increased risk of PMS and premenstrual symptoms
in physically active versus physically inactive women. Additionally, a recent study examining
obesity and PMS found that the prevalence of premenstrual symptoms was significantly higher
in obese women compared to underweight women (OR = 2.9, 95% CI: 1.1–7.5) [24]. Overall,
previous studies have had inconsistent findings, and no association has been found between
physical activity and decreased premenstrual symptoms after controlling for BMI, a factor that
likely contributes to PMS [23].
Previous studies have hypothesized that frequent physical activity prevents premenstrual
symptoms from developing and improves existing monthly symptoms. Some studies have
shown that increasing physical activity improves severity of symptoms within 3 months of start-
ing an exercise regimen [16,17,19]. Despite the potential biological connections between physi-
cal activity and endorphin levels [5,8], decreased levels of sex hormones [9,10], improvement of
oxygen in muscles [9], and a reduction of cortisol levels [9], studies remain largely inconsistent
on linking physical activity and reduced premenstrual symptoms. In a study designed similarly
to ours, 45.3% of physically active college-aged women had high premenstrual symptom scores
compared to 30.6% of college-aged sedentary women based on a self-reported questionnaire on
symptom severity [22]. To the contrary, a study that included 748 college-aged women found
that the percentage of women experiencing premenstrual and menstrual low back pain, pre-
menstrual and menstrual pelvic pain, premenstrual and menstrual headache, premenstrual
nervousness, irritability, anxiety, depression and fatigue were all significantly higher (p<0.05)
in women studying in other programs compared to those studying at the Institute of Physical
Education. These findings, however, were based on the assumption that physical education stu-
dents were more active, though this assumption was not validated [15].
We did not exclude women using oral contraceptives from our study for several reasons.
Oral contraceptive use was highly prevalent in our study population of young college-aged
women. Excluding women using such a common medication would have substantially limited
the generalizability of our findings, as well as our statistical power to detect associations. While
Table 1. (Continued)
Characteristics§ Total Sample PMS Case PMS Control p-value†
n = 414 n = 80 n = 89
• Yes 46 (11.1) 14 (17.5) 7 (7.9) 0.06
• No 368 (88.9) 66 (82.5) 82 (92.1)
*Numbers/percentages may not sum to column total due to missing data; n = 348 (n = 76 controls and n = 61 cases) for calcium, vitamin B6, alcohol, and
caffeine intake;
§Values are n (%) for categorical variables and mean ± standard deviation for continuous variables;
†P-values from Likelihood ratio χ2 test for categorical variables and Student’s t-test for continuous variables comparing PMS cases and controls.
doi:10.1371/journal.pone.0169728.t001
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oral contraceptives are sometimes used to treat menstrual symptoms, we did not find that
prevalence of oral contraceptive use varied between PMS cases and controls in our study, or
that oral contraceptive use confounded the association between physical activity and either
Table 2. Severity of premenstrual symptoms* of all study participants (n = 414) and of women meeting PMS case (n = 80) and control criteria
(n = 89).
Total Sample PMS Case PMS Control p-value§
n = 414 n = 80 n = 89
Mean ± SD Mean ± SD Mean ± SD
Physical Symptoms
• Abdominal bloating 2.2 ± 0.8 2.7 ± 0.7 1.6 ± 0.5 <0.01
• Abdominal cramping 2.3 ± 1.0 2.7 ± 1.1 1.5 ± 0.5 <0.01
• Acne 2.1 ± 0.8 2.2 ± 0.8 1.8 ± 0.7 0.04
• Back pain 1.9 ± 0.9 2.4 ± 1.1 1.4 ± 0.5 <0.01
• Breast tenderness 2.0 ± 1.0 2.4 ± 1.0 1.4 ± 0.5 <0.01
• Confusion 1.1 ± 0.4 1.2 ± 0.5 1.0 ± 0.0 0.01
• Diarrhea/constipation 1.7 ± 0.9 2.1 ± 1.0 1.2 ± 0.4 <0.01
• Dizziness 1.2 ± 0.5 1.3 ± 0.7 1.0 ± 0.0 <0.01
• Fatigue 2.1 ± 1.0 2.5 ± 0.9 1.2 ± 0.4 <0.01
• Food cravings 2.4 ± 1.1 3.0 ± 1.0 1.5 ± 0.7 <0.01
• Forgetfulness 1.2 ± 0.5 1.3 ± 0.5 1.0 ± 0.2 0.02
• Headache 1.7 ± 0.9 1.9 ± 1.0 1.3 ± 0.5 <0.01
• Hot flashes 1.3 ± 0.7 1.5 ± 0.9 1.0 ± 0.0 <0.01
• Increased/decreased appetite 2.2 ± 1.0 2.7 ± 0.8 1.4 ± 0.6 <0.01
• Insomnia 1.2 ± 0.6 1.5 ± 0.7 1.0 ± 0.0 <0.01
• Nausea 1.3 ± 0.6 1.5 ± 0.7 1.1 ± 0.2 <0.01
• Palpitations 1.1 ± 0.3 1.1 ± 0.3 1.0 ± 0.0 0.04
• Swelling in extremities 1.1 ± 0.3 1.1 ± 0.4 1.0 ± 0.0 0.01
Total physical score (sum of symptoms) 28.5 ± 6.9 35.0 ± 6.8 22.2 ± 2.3 <0.01
Affective Symptoms
• Angry outbursts 1.8 ± 0.9 2.2 ± 0.9 1.0 ± 0.2 <0.01
• Anxiety/nervousness 1.8 ± 1.0 2.2 ± 1.0 1.1 ± 0.3 <0.01
• Depression 1.5 ± 0.8 2.1 ± 0.9 1.0 ± 0.2 <0.01
• Desire to be alone 1.8 ± 0.9 2.4 ± 0.9 1.1 ± 0.3 <0.01
• Emotional hypersensitivity 2.6 ± 1.0 3.3 ± 0.7 1.4 ± 0.5 <0.01
• Irritability 2.5 ± 1.1 3.3 ± 0.8 1.4 ± 0.5 <0.01
• Mood swings 2.4 ± 1.1 3.0 ± 0.8 1.2 ± 0.4 <0.01
• Tendency to cry easily 2.4 ± 1.2 3.3 ± 0.9 1.2 ± 0.4 <0.01
Total affective score (sum of symptoms) 14.7 ± 5.5 20.9 ± 4.7 10.0 ± 1.8 <0.01
Total symptom score (sum of all symptoms) 43.1 ± 11.5 55.8 ± 9.7 32.3 ± 3.4 <0.01
Impact on Activities/Relationships
• Relationship discord with family or partner 1.7 ± 0.8 2.2 ± 0.8 1.1 ± 0.3 <0.01
• Relationship discord with friends or coworkers 1.4 ± 0.6 1.7 ± 0.7 1.0 ± 0.2 <0.01
• Poor work performance/attendance 1.4 ± 0.7 1.7 ± 0.8 1.0 ± 0.0 <0.01
• Social isolation 1.8 ± 0.9 2.2 ± 1.0 1.0 ± 0.2 <0.01
*Point values are assigned to each symptom where none = 1; mild = 2; moderate = 3; severe = 4. Symptoms are reported by participants as being
experienced most months of the year for at least several days before the start of menstruation;.
§P-values from Student’s t-test for continuous variables comparing PMS cases and controls.
doi:10.1371/journal.pone.0169728.t002
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PMS or menstrual symptom severity. Furthermore, in previous population-based studies of
PMS conducted by our research team in the Nurses’ Health Study 2 cohort, we have directly
assessed whether oral contraceptive use modifies associations between dietary, lifestyle and
demographic factors and PMS [34–39]. In all of these studies, we found no difference in results
with and without exclusion of oral contraceptive users. Thus, we included oral contraceptive
users to maximize our generalizability, power, and consistency with other population-based
studies of PMS.
Our study is limited by its cross-sectional study design and cannot explicitly address
whether exercise can treat symptoms. The relation of physical activity to symptom experience
is complex and multifaceted, and exercise may have benefits for overall well-being among
women with menstrual symptoms that are not captured by our analyses. Additionally, we are
unable to determine temporality in the physical activity and PMS relationship, where women
with symptoms may exercise more to treat their symptoms, as is recommended by the Ameri-
can Congress of Obstetricians and Gynecologists and other groups [40,41]. Temporality bias
in our study would bias our results depending on the scenario. Assuming that physical activity
is protective, we would expect cases to be less physically active than controls. If cases had
Table 3. Association between METs* and premenstrual symptom scores, among all participants (n = 414).
Model 1§ Model 2† Model 3‡ Model 4ψ
Score β SEβ p-value β SEβ p-value β SEβ p-value β SEβ p-value
Total symptom score 0.03 0.11 0.76 0.03 0.11 0.80 0.10 0.11 0.40 0.06 0.11 0.62
Affective symptom score 0.05 0.05 0.34 0.05 0.05 0.35 0.07 0.06 0.19 0.07 0.06 0.23
Physical symptom score -0.02 0.07 0.78 -0.02 0.07 0.74 0.02 0.07 0.73 -0.01 0.07 0.88
*per 10 METs/week;
§Adjusted for age;
†Adjusted for age and BMI;
‡Adjusted for age, BMI, ever smoker, age at first menses, calcium intake;
ψ Adjusted for age, BMI, ever smoker, age at first menses, calcium intake, and reports treating symptoms with exercise.
doi:10.1371/journal.pone.0169728.t003
Table 4. Odds ratios and confidence intervals for the association of physical activity and PMS*.
Cases
(n = 80)
Controls
(n = 89)
Model 1§ Model 2† Model 3‡ Model 4ψ
n (%) OR (95% CI)
Physical activity (Median, METs
per week)
• Tertile 1 (16.3) 24 (30.0) 28 (31.5) 1.0 (Referent) 1.0 (Referent) 1.0 (Referent) (Referent)
• Tertile 2 (39.3) 34 (42.5) 29 (32.6) 1.4 (0.7–2.9) 1.4 (0.7–3.0) 1.5 (0.6–3.7) (0.6–3.5)
• Tertile 3 (90.5) 22 (27.5) 32 (36.0) 0.8 (0.4–1.7) 0.8 (0.4–1.7) 0.9 (0.4–2.4) 0.9 (0.3–2.2)
Mean ± SD Mean ± SD
Physical Activity (per 10 METs/
week)
4.7 ± 3.7 5.5 ± 4.4 0.995 (0.988–
1.003)
0.995 (0.988–
1.003)
0.999 (0.991–
1.007)
0.998 (0.990–
1.006)
*Among cases and controls (n = 169);
§Adjusted for age;
†Adjusted for age and BMI;
‡Adjusted for age, BMI, ever smoker, age at first menses, calcium intake; Hosmer and Lemeshow Goodness-of-Fit p = 0.8264 for physical activity tertile
model, p = 0.9615 for continuous physical activity model;
ψ Adjusted for age, BMI, ever smoker, age at first menses, calcium intake, and reports treating symptoms with exercise.
doi:10.1371/journal.pone.0169728.t004
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higher than expected levels of physical activity, our results would bias toward the null as the
exposure levels between cases and controls would be more similar.
Alternatively, if cases become less physically active due to more severe premenstrual symp-
toms, overall physical activity levels would decrease and bias our results away from the null
(making exercise look more protective). This may provide an explanation for previous studies
that found an effect. However, we were able to consider whether a participant reported using
exercise to help treat premenstrual symptoms, and developed a model to examine reverse cau-
sality [42]. This variable did not change the directionality or strength of our findings when
added to models as a covariate. However, total and physical symptoms scores were signifi-
cantly higher in those reporting exercise to treat symptoms, providing evidence that reverse
causation is possible.
Strengths of our study include the large range in exercise reported by our participants (0.0–
374.3 METs/week), which provided good power to detect an association if one existed. We
also used validated PMS and premenstrual symptom questionnaires, which had high sensitiv-
ity and specificity for categorizing cases and controls [29,30]. Given the nature of the main
study to examine vitamin D status, it is unlikely that we would have been affected by selection
bias in this present analysis. Recall bias is also unlikely, as women were asked to report usual
symptoms and most of our participants had regular menstrual cycle lengths. Additionally, in
our symptom models, we had a broad range of values for all three score variables. Finally, we
assessed the impact of many potential confounders, including diet, oral contraceptive use,
BMI, menstrual cycle characteristics, and smoking history.
Conclusions
In conclusion, our results do not support an inverse physiologic relation between physical activ-
ity and the prevalence of PMS or the severity of premenstrual symptoms. Instead, our results
suggest that women experiencing a greater number of physical premenstrual symptoms are
more likely to exercise than women reporting fewer premenstrual symptoms. Ours is among
the first studies to directly consider whether the suggested benefits of exercise for treating PMS
may be attributable to reverse causation. These findings contribute further evidence that
increasing physical activity may not be effective for treating moderate to severe PMS. Instead,
women experiencing significant PMS may receive greater benefit from following clinical recom-
mendations supported by more evidence, such as dietary modifications and medication use.
Supporting Information
S1 Appendix. Supplemental Information on the Definition of PMS Cases and Controls.
(DOCX)
Table 5. Association of symptom scores with use of exercise to treat menstrual symptoms in partici-
pants (n = 414).
Model Results*
Score β SEβ p-value
Total symptom score 2.96 1.32 0.03
Affective symptom score 0.42 0.65 0.52
Physical symptom score 2.54 0.80 <0.01
*Adjusted for physical activity in 10 METs/week, age, BMI, ever smoker, age at first menses, and calcium
intake; Note: β values are reported for the difference between women reporting yes to use of exercise to
treat symptoms (n = 107) compared to women not reporting use of exercise to treat symptoms (n = 307).
doi:10.1371/journal.pone.0169728.t005
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